nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCB1—ovarian cancer	0.101	1	CbGaD
Verapamil—SLCO1A2—Chlorambucil—ovarian cancer	0.0634	0.0982	CbGbCtD
Verapamil—ABCC10—Paclitaxel—ovarian cancer	0.0631	0.0977	CbGbCtD
Verapamil—ABCC10—Docetaxel—ovarian cancer	0.0456	0.0707	CbGbCtD
Verapamil—ABCB11—Paclitaxel—ovarian cancer	0.0343	0.0531	CbGbCtD
Verapamil—ABCC10—Doxorubicin—ovarian cancer	0.034	0.0527	CbGbCtD
Verapamil—ABCG2—Topotecan—ovarian cancer	0.0329	0.051	CbGbCtD
Verapamil—ABCC1—Epirubicin—ovarian cancer	0.0247	0.0383	CbGbCtD
Verapamil—ABCC1—Paclitaxel—ovarian cancer	0.0244	0.0377	CbGbCtD
Verapamil—ABCC3—Doxorubicin—ovarian cancer	0.0214	0.0331	CbGbCtD
Verapamil—ABCB11—Doxorubicin—ovarian cancer	0.0185	0.0286	CbGbCtD
Verapamil—ABCC2—Paclitaxel—ovarian cancer	0.018	0.0279	CbGbCtD
Verapamil—ABCC1—Docetaxel—ovarian cancer	0.0176	0.0273	CbGbCtD
Verapamil—ABCC2—Carboplatin—ovarian cancer	0.017	0.0263	CbGbCtD
Verapamil—ABCG2—Paclitaxel—ovarian cancer	0.0163	0.0252	CbGbCtD
Verapamil—ABCG2—Carboplatin—ovarian cancer	0.0153	0.0238	CbGbCtD
Verapamil—ABCC1—Doxorubicin—ovarian cancer	0.0131	0.0203	CbGbCtD
Verapamil—ABCC2—Docetaxel—ovarian cancer	0.013	0.0202	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.012	0.0186	CbGbCtD
Verapamil—CYP3A7—Paclitaxel—ovarian cancer	0.012	0.0186	CbGbCtD
Verapamil—ABCB1—Topotecan—ovarian cancer	0.0119	0.0184	CbGbCtD
Verapamil—ABCG2—Docetaxel—ovarian cancer	0.0118	0.0183	CbGbCtD
Verapamil—ABCC2—Doxorubicin—ovarian cancer	0.00972	0.0151	CbGbCtD
Verapamil—CYP3A5—Paclitaxel—ovarian cancer	0.00903	0.014	CbGbCtD
Verapamil—ABCG2—Doxorubicin—ovarian cancer	0.00879	0.0136	CbGbCtD
Verapamil—CYP3A7—Docetaxel—ovarian cancer	0.00871	0.0135	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.00871	0.0135	CbGbCtD
Verapamil—CYP2C8—Paclitaxel—ovarian cancer	0.00869	0.0135	CbGbCtD
Verapamil—ABCB1—Vinorelbine—ovarian cancer	0.00837	0.013	CbGbCtD
Verapamil—CYP2D6—Vinorelbine—ovarian cancer	0.00788	0.0122	CbGbCtD
Verapamil—CYP3A4—Topotecan—ovarian cancer	0.00712	0.011	CbGbCtD
Verapamil—CYP3A5—Docetaxel—ovarian cancer	0.00653	0.0101	CbGbCtD
Verapamil—CYP2B6—Doxorubicin—ovarian cancer	0.00618	0.00957	CbGbCtD
Verapamil—CYP2C9—Paclitaxel—ovarian cancer	0.00606	0.00938	CbGbCtD
Verapamil—ABCB1—Paclitaxel—ovarian cancer	0.00588	0.0091	CbGbCtD
Verapamil—CYP3A4—Vinorelbine—ovarian cancer	0.00501	0.00776	CbGbCtD
Verapamil—ABCB1—Docetaxel—ovarian cancer	0.00425	0.00658	CbGbCtD
Verapamil—CYP3A4—Paclitaxel—ovarian cancer	0.00352	0.00545	CbGbCtD
Verapamil—ABCB1—Doxorubicin—ovarian cancer	0.00317	0.00491	CbGbCtD
Verapamil—CYP2D6—Doxorubicin—ovarian cancer	0.00299	0.00462	CbGbCtD
Verapamil—CYP3A4—Docetaxel—ovarian cancer	0.00255	0.00394	CbGbCtD
Verapamil—CYP3A4—Doxorubicin—ovarian cancer	0.0019	0.00294	CbGbCtD
Verapamil—CACNB3—myometrium—ovarian cancer	0.00168	0.0232	CbGeAlD
Verapamil—CACNA1G—decidua—ovarian cancer	0.00135	0.0187	CbGeAlD
Verapamil—CACNB3—uterine cervix—ovarian cancer	0.0013	0.0181	CbGeAlD
Verapamil—CACNA1I—testis—ovarian cancer	0.00125	0.0173	CbGeAlD
Verapamil—CACNB3—decidua—ovarian cancer	0.00124	0.0172	CbGeAlD
Verapamil—CACNA1H—myometrium—ovarian cancer	0.00119	0.0165	CbGeAlD
Verapamil—CACNB3—endometrium—ovarian cancer	0.00118	0.0163	CbGeAlD
Verapamil—CACNB4—vagina—ovarian cancer	0.00115	0.016	CbGeAlD
Verapamil—CACNB3—uterus—ovarian cancer	0.00109	0.015	CbGeAlD
Verapamil—CYP2C18—uterine cervix—ovarian cancer	0.00104	0.0144	CbGeAlD
Verapamil—CACNB4—testis—ovarian cancer	0.00103	0.0143	CbGeAlD
Verapamil—CACNA1A—testis—ovarian cancer	0.000983	0.0136	CbGeAlD
Verapamil—CACNB3—female reproductive system—ovarian cancer	0.000977	0.0135	CbGeAlD
Verapamil—CACNA1B—testis—ovarian cancer	0.000959	0.0133	CbGeAlD
Verapamil—CACNB1—female gonad—ovarian cancer	0.000927	0.0128	CbGeAlD
Verapamil—CACNA1C—myometrium—ovarian cancer	0.000908	0.0126	CbGeAlD
Verapamil—CACNA1I—lymph node—ovarian cancer	0.000907	0.0126	CbGeAlD
Verapamil—CACNB3—female gonad—ovarian cancer	0.000889	0.0123	CbGeAlD
Verapamil—CACNB3—vagina—ovarian cancer	0.000884	0.0122	CbGeAlD
Verapamil—ABCC10—myometrium—ovarian cancer	0.000822	0.0114	CbGeAlD
Verapamil—CACNB1—testis—ovarian cancer	0.000822	0.0114	CbGeAlD
Verapamil—CACNB3—testis—ovarian cancer	0.000788	0.0109	CbGeAlD
Verapamil—CACNA1H—gonad—ovarian cancer	0.000778	0.0108	CbGeAlD
Verapamil—CACNA1H—uterus—ovarian cancer	0.000773	0.0107	CbGeAlD
Verapamil—SLC22A4—myometrium—ovarian cancer	0.000773	0.0107	CbGeAlD
Verapamil—CACNA1D—uterine cervix—ovarian cancer	0.000766	0.0106	CbGeAlD
Verapamil—CYP2C18—vagina—ovarian cancer	0.000704	0.00974	CbGeAlD
Verapamil—CACNA1B—lymph node—ovarian cancer	0.000695	0.00963	CbGeAlD
Verapamil—CACNA1H—female reproductive system—ovarian cancer	0.000695	0.00962	CbGeAlD
Verapamil—CACNA1C—decidua—ovarian cancer	0.000673	0.00932	CbGeAlD
Verapamil—ABCC10—uterine cervix—ovarian cancer	0.00064	0.00886	CbGeAlD
Verapamil—CACNA1H—female gonad—ovarian cancer	0.000632	0.00876	CbGeAlD
Verapamil—KCNJ11—female reproductive system—ovarian cancer	0.000623	0.00862	CbGeAlD
Verapamil—ABCC3—decidua—ovarian cancer	0.000613	0.00848	CbGeAlD
Verapamil—ABCB11—testis—ovarian cancer	0.000611	0.00846	CbGeAlD
Verapamil—ABCC10—decidua—ovarian cancer	0.00061	0.00844	CbGeAlD
Verapamil—CACNB1—lymph node—ovarian cancer	0.000596	0.00825	CbGeAlD
Verapamil—CACNB2—vagina—ovarian cancer	0.000594	0.00822	CbGeAlD
Verapamil—ABCC1—myometrium—ovarian cancer	0.000582	0.00805	CbGeAlD
Verapamil—ABCC10—endometrium—ovarian cancer	0.000579	0.00801	CbGeAlD
Verapamil—SLC22A4—decidua—ovarian cancer	0.000573	0.00793	CbGeAlD
Verapamil—CACNB3—lymph node—ovarian cancer	0.000571	0.00791	CbGeAlD
Verapamil—KCNJ11—female gonad—ovarian cancer	0.000567	0.00785	CbGeAlD
Verapamil—CACNA1H—testis—ovarian cancer	0.000561	0.00777	CbGeAlD
Verapamil—SLC22A4—endometrium—ovarian cancer	0.000544	0.00753	CbGeAlD
Verapamil—KCNH2—myometrium—ovarian cancer	0.000541	0.00749	CbGeAlD
Verapamil—ABCC10—gonad—ovarian cancer	0.000537	0.00743	CbGeAlD
Verapamil—ABCC10—uterus—ovarian cancer	0.000533	0.00738	CbGeAlD
Verapamil—CACNB2—testis—ovarian cancer	0.00053	0.00733	CbGeAlD
Verapamil—CACNA1C—female reproductive system—ovarian cancer	0.00053	0.00733	CbGeAlD
Verapamil—SLC22A5—myometrium—ovarian cancer	0.000511	0.00708	CbGeAlD
Verapamil—SLCO1B1—female reproductive system—ovarian cancer	0.000508	0.00703	CbGeAlD
Verapamil—ABCC3—female reproductive system—ovarian cancer	0.000482	0.00667	CbGeAlD
Verapamil—ABCG2—myometrium—ovarian cancer	0.000481	0.00667	CbGeAlD
Verapamil—ABCC10—female reproductive system—ovarian cancer	0.000479	0.00664	CbGeAlD
Verapamil—CACNA1C—vagina—ovarian cancer	0.000479	0.00663	CbGeAlD
Verapamil—SCN5A—vagina—ovarian cancer	0.000464	0.00643	CbGeAlD
Verapamil—CACNA1D—testis—ovarian cancer	0.000463	0.00641	CbGeAlD
Verapamil—ABCC10—bone marrow—ovarian cancer	0.000453	0.00627	CbGeAlD
Verapamil—ABCC1—uterine cervix—ovarian cancer	0.000453	0.00627	CbGeAlD
Verapamil—SLC22A4—female reproductive system—ovarian cancer	0.000451	0.00624	CbGeAlD
Verapamil—ABCC4—uterus—ovarian cancer	0.000442	0.00612	CbGeAlD
Verapamil—ABCC3—female gonad—ovarian cancer	0.000438	0.00607	CbGeAlD
Verapamil—ABCC10—female gonad—ovarian cancer	0.000436	0.00604	CbGeAlD
Verapamil—ABCC10—vagina—ovarian cancer	0.000434	0.006	CbGeAlD
Verapamil—ABCC1—decidua—ovarian cancer	0.000431	0.00597	CbGeAlD
Verapamil—CACNA1C—testis—ovarian cancer	0.000427	0.00592	CbGeAlD
Verapamil—SLC22A4—bone marrow—ovarian cancer	0.000425	0.00589	CbGeAlD
Verapamil—KCNH2—uterine cervix—ovarian cancer	0.000421	0.00583	CbGeAlD
Verapamil—ABCC1—endometrium—ovarian cancer	0.000409	0.00567	CbGeAlD
Verapamil—SLC22A4—vagina—ovarian cancer	0.000408	0.00564	CbGeAlD
Verapamil—CACNA1H—lymph node—ovarian cancer	0.000407	0.00563	CbGeAlD
Verapamil—SLC6A4—female reproductive system—ovarian cancer	0.000399	0.00553	CbGeAlD
Verapamil—SLC22A5—uterine cervix—ovarian cancer	0.000398	0.00551	CbGeAlD
Verapamil—ABCC4—female reproductive system—ovarian cancer	0.000398	0.00551	CbGeAlD
Verapamil—ABCC3—testis—ovarian cancer	0.000389	0.00538	CbGeAlD
Verapamil—SLC22A1—vagina—ovarian cancer	0.000388	0.00537	CbGeAlD
Verapamil—ABCC10—testis—ovarian cancer	0.000387	0.00536	CbGeAlD
Verapamil—ABCC2—female reproductive system—ovarian cancer	0.000385	0.00533	CbGeAlD
Verapamil—CACNB2—lymph node—ovarian cancer	0.000384	0.00532	CbGeAlD
Verapamil—KCNH2—endometrium—ovarian cancer	0.000381	0.00527	CbGeAlD
Verapamil—ABCC1—uterus—ovarian cancer	0.000377	0.00522	CbGeAlD
Verapamil—ABCC4—bone marrow—ovarian cancer	0.000375	0.0052	CbGeAlD
Verapamil—ABCG2—uterine cervix—ovarian cancer	0.000375	0.00519	CbGeAlD
Verapamil—KCNJ11—lymph node—ovarian cancer	0.000364	0.00504	CbGeAlD
Verapamil—ABCC4—female gonad—ovarian cancer	0.000362	0.00501	CbGeAlD
Verapamil—SLC22A5—endometrium—ovarian cancer	0.00036	0.00498	CbGeAlD
Verapamil—ABCG2—decidua—ovarian cancer	0.000357	0.00494	CbGeAlD
Verapamil—KCNH2—uterus—ovarian cancer	0.000351	0.00486	CbGeAlD
Verapamil—CYP2C8—endometrium—ovarian cancer	0.000348	0.00483	CbGeAlD
Verapamil—CYP3A5—uterine cervix—ovarian cancer	0.000348	0.00482	CbGeAlD
Verapamil—ABCG2—endometrium—ovarian cancer	0.000339	0.00469	CbGeAlD
Verapamil—CACNA1D—lymph node—ovarian cancer	0.000336	0.00465	CbGeAlD
Verapamil—SLCO1A2—testis—ovarian cancer	0.000333	0.00462	CbGeAlD
Verapamil—ABCC4—testis—ovarian cancer	0.000321	0.00444	CbGeAlD
Verapamil—KCNH2—female reproductive system—ovarian cancer	0.000316	0.00437	CbGeAlD
Verapamil—ABCG2—uterus—ovarian cancer	0.000312	0.00432	CbGeAlD
Verapamil—ABCC2—testis—ovarian cancer	0.000311	0.0043	CbGeAlD
Verapamil—CACNA1C—lymph node—ovarian cancer	0.00031	0.00429	CbGeAlD
Verapamil—ABCC1—female gonad—ovarian cancer	0.000309	0.00427	CbGeAlD
Verapamil—ABCC1—vagina—ovarian cancer	0.000307	0.00425	CbGeAlD
Verapamil—CYP2C19—vagina—ovarian cancer	0.000299	0.00414	CbGeAlD
Verapamil—SLC22A5—female reproductive system—ovarian cancer	0.000298	0.00413	CbGeAlD
Verapamil—KCNH2—bone marrow—ovarian cancer	0.000298	0.00412	CbGeAlD
Verapamil—CYP2B6—gonad—ovarian cancer	0.00029	0.00401	CbGeAlD
Verapamil—CYP2C8—female reproductive system—ovarian cancer	0.000289	0.004	CbGeAlD
Verapamil—KCNH2—female gonad—ovarian cancer	0.000287	0.00398	CbGeAlD
Verapamil—KCNH2—vagina—ovarian cancer	0.000285	0.00395	CbGeAlD
Verapamil—ABCC3—lymph node—ovarian cancer	0.000282	0.0039	CbGeAlD
Verapamil—ABCC10—lymph node—ovarian cancer	0.00028	0.00388	CbGeAlD
Verapamil—ABCC1—testis—ovarian cancer	0.000274	0.00379	CbGeAlD
Verapamil—SLC22A5—female gonad—ovarian cancer	0.000271	0.00376	CbGeAlD
Verapamil—SLC22A5—vagina—ovarian cancer	0.00027	0.00373	CbGeAlD
Verapamil—ABCG2—bone marrow—ovarian cancer	0.000265	0.00367	CbGeAlD
Verapamil—SLC22A4—lymph node—ovarian cancer	0.000264	0.00365	CbGeAlD
Verapamil—CYP2C8—vagina—ovarian cancer	0.000261	0.00362	CbGeAlD
Verapamil—CYP2B6—female reproductive system—ovarian cancer	0.000259	0.00359	CbGeAlD
Verapamil—CYP2C9—female reproductive system—ovarian cancer	0.000256	0.00355	CbGeAlD
Verapamil—ABCG2—female gonad—ovarian cancer	0.000255	0.00354	CbGeAlD
Verapamil—KCNH2—testis—ovarian cancer	0.000255	0.00353	CbGeAlD
Verapamil—ABCG2—vagina—ovarian cancer	0.000254	0.00352	CbGeAlD
Verapamil—SLC22A5—testis—ovarian cancer	0.000241	0.00333	CbGeAlD
Verapamil—ABCB1—myometrium—ovarian cancer	0.000237	0.00329	CbGeAlD
Verapamil—CYP3A5—female gonad—ovarian cancer	0.000237	0.00328	CbGeAlD
Verapamil—CYP3A5—vagina—ovarian cancer	0.000236	0.00326	CbGeAlD
Verapamil—CYP2B6—vagina—ovarian cancer	0.000234	0.00324	CbGeAlD
Verapamil—CYP2C8—testis—ovarian cancer	0.000233	0.00323	CbGeAlD
Verapamil—ABCC4—lymph node—ovarian cancer	0.000233	0.00322	CbGeAlD
Verapamil—ABCB1—embryo—ovarian cancer	0.000228	0.00316	CbGeAlD
Verapamil—ABCG2—testis—ovarian cancer	0.000227	0.00314	CbGeAlD
Verapamil—ABCC2—lymph node—ovarian cancer	0.000225	0.00312	CbGeAlD
Verapamil—CYP2B6—testis—ovarian cancer	0.000209	0.00289	CbGeAlD
Verapamil—ABCC1—lymph node—ovarian cancer	0.000198	0.00275	CbGeAlD
Verapamil—CYP3A4—female reproductive system—ovarian cancer	0.000196	0.00271	CbGeAlD
Verapamil—CYP2D6—female reproductive system—ovarian cancer	0.000192	0.00266	CbGeAlD
Verapamil—Lethargy—Epirubicin—ovarian cancer	0.00019	0.00194	CcSEcCtD
Verapamil—Pharyngitis—Docetaxel—ovarian cancer	0.00019	0.00194	CcSEcCtD
Verapamil—Urticaria—Vinorelbine—ovarian cancer	0.000189	0.00193	CcSEcCtD
Verapamil—Muscle spasms—Paclitaxel—ovarian cancer	0.000189	0.00193	CcSEcCtD
Verapamil—Oedema peripheral—Docetaxel—ovarian cancer	0.000188	0.00193	CcSEcCtD
Verapamil—Diarrhoea—Melphalan—ovarian cancer	0.000186	0.00191	CcSEcCtD
Verapamil—ABCB1—epithelium—ovarian cancer	0.000186	0.00258	CbGeAlD
Verapamil—Diplopia—Epirubicin—ovarian cancer	0.000186	0.00191	CcSEcCtD
Verapamil—Nausea—Chlorambucil—ovarian cancer	0.000186	0.0019	CcSEcCtD
Verapamil—Vision blurred—Paclitaxel—ovarian cancer	0.000185	0.00189	CcSEcCtD
Verapamil—ABCB1—uterine cervix—ovarian cancer	0.000185	0.00256	CbGeAlD
Verapamil—KCNH2—lymph node—ovarian cancer	0.000185	0.00256	CbGeAlD
Verapamil—Visual impairment—Docetaxel—ovarian cancer	0.000184	0.00188	CcSEcCtD
Verapamil—Dizziness—Topotecan—ovarian cancer	0.000184	0.00188	CcSEcCtD
Verapamil—Tremor—Paclitaxel—ovarian cancer	0.000184	0.00188	CcSEcCtD
Verapamil—Erythema multiforme—Docetaxel—ovarian cancer	0.000181	0.00185	CcSEcCtD
Verapamil—Agitation—Paclitaxel—ovarian cancer	0.00018	0.00184	CcSEcCtD
Verapamil—Angioedema—Paclitaxel—ovarian cancer	0.000179	0.00183	CcSEcCtD
Verapamil—Purpura—Doxorubicin—ovarian cancer	0.000179	0.00183	CcSEcCtD
Verapamil—Flushing—Docetaxel—ovarian cancer	0.000177	0.00181	CcSEcCtD
Verapamil—Cardiac arrest—Epirubicin—ovarian cancer	0.000177	0.00181	CcSEcCtD
Verapamil—Vomiting—Topotecan—ovarian cancer	0.000177	0.00181	CcSEcCtD
Verapamil—Cardiac failure—Doxorubicin—ovarian cancer	0.000177	0.00181	CcSEcCtD
Verapamil—Vertigo—Paclitaxel—ovarian cancer	0.000176	0.0018	CcSEcCtD
Verapamil—ABCB1—decidua—ovarian cancer	0.000176	0.00244	CbGeAlD
Verapamil—Syncope—Paclitaxel—ovarian cancer	0.000176	0.0018	CcSEcCtD
Verapamil—Lethargy—Doxorubicin—ovarian cancer	0.000176	0.0018	CcSEcCtD
Verapamil—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000176	0.0018	CcSEcCtD
Verapamil—Rash—Topotecan—ovarian cancer	0.000176	0.0018	CcSEcCtD
Verapamil—Hypersensitivity—Vinorelbine—ovarian cancer	0.000175	0.00179	CcSEcCtD
Verapamil—Dermatitis—Topotecan—ovarian cancer	0.000175	0.00179	CcSEcCtD
Verapamil—CYP2D6—female gonad—ovarian cancer	0.000175	0.00242	CbGeAlD
Verapamil—SLC22A5—lymph node—ovarian cancer	0.000174	0.00242	CbGeAlD
Verapamil—Headache—Topotecan—ovarian cancer	0.000174	0.00178	CcSEcCtD
Verapamil—Palpitations—Paclitaxel—ovarian cancer	0.000173	0.00177	CcSEcCtD
Verapamil—Vomiting—Melphalan—ovarian cancer	0.000173	0.00177	CcSEcCtD
Verapamil—Loss of consciousness—Paclitaxel—ovarian cancer	0.000172	0.00176	CcSEcCtD
Verapamil—Diplopia—Doxorubicin—ovarian cancer	0.000172	0.00176	CcSEcCtD
Verapamil—Rash—Melphalan—ovarian cancer	0.000172	0.00176	CcSEcCtD
Verapamil—Dermatitis—Melphalan—ovarian cancer	0.000172	0.00176	CcSEcCtD
Verapamil—Asthenia—Vinorelbine—ovarian cancer	0.000171	0.00175	CcSEcCtD
Verapamil—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00017	0.00174	CcSEcCtD
Verapamil—Convulsion—Paclitaxel—ovarian cancer	0.00017	0.00174	CcSEcCtD
Verapamil—Hypertension—Paclitaxel—ovarian cancer	0.000169	0.00173	CcSEcCtD
Verapamil—Alopecia—Docetaxel—ovarian cancer	0.000169	0.00173	CcSEcCtD
Verapamil—Pruritus—Vinorelbine—ovarian cancer	0.000168	0.00172	CcSEcCtD
Verapamil—ABCB1—endometrium—ovarian cancer	0.000167	0.00231	CbGeAlD
Verapamil—Myalgia—Paclitaxel—ovarian cancer	0.000167	0.00171	CcSEcCtD
Verapamil—Arthralgia—Paclitaxel—ovarian cancer	0.000167	0.00171	CcSEcCtD
Verapamil—Chest pain—Paclitaxel—ovarian cancer	0.000167	0.00171	CcSEcCtD
Verapamil—Nausea—Topotecan—ovarian cancer	0.000165	0.00169	CcSEcCtD
Verapamil—Discomfort—Paclitaxel—ovarian cancer	0.000165	0.00169	CcSEcCtD
Verapamil—Muscular weakness—Epirubicin—ovarian cancer	0.000164	0.00168	CcSEcCtD
Verapamil—ABCG2—lymph node—ovarian cancer	0.000164	0.00227	CbGeAlD
Verapamil—Cardiac arrest—Doxorubicin—ovarian cancer	0.000164	0.00168	CcSEcCtD
Verapamil—Dry mouth—Paclitaxel—ovarian cancer	0.000163	0.00167	CcSEcCtD
Verapamil—Diarrhoea—Vinorelbine—ovarian cancer	0.000163	0.00167	CcSEcCtD
Verapamil—Nausea—Melphalan—ovarian cancer	0.000162	0.00166	CcSEcCtD
Verapamil—Confusional state—Paclitaxel—ovarian cancer	0.000161	0.00165	CcSEcCtD
Verapamil—Influenza—Epirubicin—ovarian cancer	0.000161	0.00165	CcSEcCtD
Verapamil—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00016	0.00164	CcSEcCtD
Verapamil—Oedema—Paclitaxel—ovarian cancer	0.00016	0.00164	CcSEcCtD
Verapamil—Muscle spasms—Docetaxel—ovarian cancer	0.00016	0.00164	CcSEcCtD
Verapamil—Infection—Paclitaxel—ovarian cancer	0.000159	0.00163	CcSEcCtD
Verapamil—Shock—Paclitaxel—ovarian cancer	0.000158	0.00161	CcSEcCtD
Verapamil—Dizziness—Vinorelbine—ovarian cancer	0.000157	0.00161	CcSEcCtD
Verapamil—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000157	0.00161	CcSEcCtD
Verapamil—Angina pectoris—Epirubicin—ovarian cancer	0.000157	0.0016	CcSEcCtD
Verapamil—Tachycardia—Paclitaxel—ovarian cancer	0.000156	0.0016	CcSEcCtD
Verapamil—CYP2D6—testis—ovarian cancer	0.000155	0.00215	CbGeAlD
Verapamil—ABCB1—gonad—ovarian cancer	0.000155	0.00215	CbGeAlD
Verapamil—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000155	0.00158	CcSEcCtD
Verapamil—ABCB1—uterus—ovarian cancer	0.000154	0.00213	CbGeAlD
Verapamil—Muscular weakness—Doxorubicin—ovarian cancer	0.000152	0.00156	CcSEcCtD
Verapamil—Vomiting—Vinorelbine—ovarian cancer	0.000151	0.00155	CcSEcCtD
Verapamil—Rash—Vinorelbine—ovarian cancer	0.00015	0.00154	CcSEcCtD
Verapamil—Dermatitis—Vinorelbine—ovarian cancer	0.00015	0.00153	CcSEcCtD
Verapamil—Hypotension—Paclitaxel—ovarian cancer	0.00015	0.00153	CcSEcCtD
Verapamil—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.00015	0.00153	CcSEcCtD
Verapamil—Headache—Vinorelbine—ovarian cancer	0.000149	0.00153	CcSEcCtD
Verapamil—Syncope—Docetaxel—ovarian cancer	0.000149	0.00153	CcSEcCtD
Verapamil—Influenza—Doxorubicin—ovarian cancer	0.000149	0.00152	CcSEcCtD
Verapamil—Pollakiuria—Epirubicin—ovarian cancer	0.000149	0.00152	CcSEcCtD
Verapamil—Palpitations—Docetaxel—ovarian cancer	0.000147	0.0015	CcSEcCtD
Verapamil—Loss of consciousness—Docetaxel—ovarian cancer	0.000146	0.0015	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000146	0.00149	CcSEcCtD
Verapamil—Angina pectoris—Doxorubicin—ovarian cancer	0.000145	0.00148	CcSEcCtD
Verapamil—Insomnia—Paclitaxel—ovarian cancer	0.000145	0.00148	CcSEcCtD
Verapamil—Convulsion—Docetaxel—ovarian cancer	0.000144	0.00147	CcSEcCtD
Verapamil—Paraesthesia—Paclitaxel—ovarian cancer	0.000144	0.00147	CcSEcCtD
Verapamil—Hypertension—Docetaxel—ovarian cancer	0.000144	0.00147	CcSEcCtD
Verapamil—Drowsiness—Epirubicin—ovarian cancer	0.000144	0.00147	CcSEcCtD
Verapamil—Dyspnoea—Paclitaxel—ovarian cancer	0.000143	0.00146	CcSEcCtD
Verapamil—Somnolence—Paclitaxel—ovarian cancer	0.000142	0.00146	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000142	0.00146	CcSEcCtD
Verapamil—Chest pain—Docetaxel—ovarian cancer	0.000142	0.00145	CcSEcCtD
Verapamil—Arthralgia—Docetaxel—ovarian cancer	0.000142	0.00145	CcSEcCtD
Verapamil—Myalgia—Docetaxel—ovarian cancer	0.000142	0.00145	CcSEcCtD
Verapamil—Nausea—Vinorelbine—ovarian cancer	0.000141	0.00145	CcSEcCtD
Verapamil—Dyspepsia—Paclitaxel—ovarian cancer	0.000141	0.00144	CcSEcCtD
Verapamil—Jaundice—Epirubicin—ovarian cancer	0.00014	0.00143	CcSEcCtD
Verapamil—Dry mouth—Docetaxel—ovarian cancer	0.000138	0.00142	CcSEcCtD
Verapamil—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000138	0.00142	CcSEcCtD
Verapamil—ABCB1—female reproductive system—ovarian cancer	0.000138	0.00192	CbGeAlD
Verapamil—Fatigue—Paclitaxel—ovarian cancer	0.000138	0.00141	CcSEcCtD
Verapamil—Sweating—Epirubicin—ovarian cancer	0.000138	0.00141	CcSEcCtD
Verapamil—Pollakiuria—Doxorubicin—ovarian cancer	0.000138	0.00141	CcSEcCtD
Verapamil—Constipation—Paclitaxel—ovarian cancer	0.000137	0.0014	CcSEcCtD
Verapamil—Pain—Paclitaxel—ovarian cancer	0.000137	0.0014	CcSEcCtD
Verapamil—Confusional state—Docetaxel—ovarian cancer	0.000137	0.0014	CcSEcCtD
Verapamil—Anaphylactic shock—Docetaxel—ovarian cancer	0.000136	0.00139	CcSEcCtD
Verapamil—Oedema—Docetaxel—ovarian cancer	0.000136	0.00139	CcSEcCtD
Verapamil—Infection—Docetaxel—ovarian cancer	0.000135	0.00138	CcSEcCtD
Verapamil—Sinusitis—Epirubicin—ovarian cancer	0.000135	0.00138	CcSEcCtD
Verapamil—Shock—Docetaxel—ovarian cancer	0.000134	0.00137	CcSEcCtD
Verapamil—Drowsiness—Doxorubicin—ovarian cancer	0.000133	0.00136	CcSEcCtD
Verapamil—Tachycardia—Docetaxel—ovarian cancer	0.000132	0.00136	CcSEcCtD
Verapamil—Feeling abnormal—Paclitaxel—ovarian cancer	0.000132	0.00135	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000132	0.00135	CcSEcCtD
Verapamil—Bradycardia—Epirubicin—ovarian cancer	0.000131	0.00134	CcSEcCtD
Verapamil—ABCB1—bone marrow—ovarian cancer	0.000131	0.00181	CbGeAlD
Verapamil—Jaundice—Doxorubicin—ovarian cancer	0.000129	0.00132	CcSEcCtD
Verapamil—Rhinitis—Epirubicin—ovarian cancer	0.000129	0.00132	CcSEcCtD
Verapamil—Hepatitis—Epirubicin—ovarian cancer	0.000129	0.00132	CcSEcCtD
Verapamil—Hypoaesthesia—Epirubicin—ovarian cancer	0.000128	0.00131	CcSEcCtD
Verapamil—Pharyngitis—Epirubicin—ovarian cancer	0.000128	0.00131	CcSEcCtD
Verapamil—Sweating—Doxorubicin—ovarian cancer	0.000127	0.0013	CcSEcCtD
Verapamil—Urticaria—Paclitaxel—ovarian cancer	0.000127	0.0013	CcSEcCtD
Verapamil—Oedema peripheral—Epirubicin—ovarian cancer	0.000127	0.0013	CcSEcCtD
Verapamil—Hypotension—Docetaxel—ovarian cancer	0.000127	0.0013	CcSEcCtD
Verapamil—ABCB1—female gonad—ovarian cancer	0.000126	0.00174	CbGeAlD
Verapamil—ABCB1—vagina—ovarian cancer	0.000125	0.00173	CbGeAlD
Verapamil—Sinusitis—Doxorubicin—ovarian cancer	0.000125	0.00127	CcSEcCtD
Verapamil—Visual impairment—Epirubicin—ovarian cancer	0.000124	0.00127	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000124	0.00127	CcSEcCtD
Verapamil—Insomnia—Docetaxel—ovarian cancer	0.000123	0.00126	CcSEcCtD
Verapamil—Paraesthesia—Docetaxel—ovarian cancer	0.000122	0.00125	CcSEcCtD
Verapamil—Erythema multiforme—Epirubicin—ovarian cancer	0.000122	0.00125	CcSEcCtD
Verapamil—Bradycardia—Doxorubicin—ovarian cancer	0.000121	0.00124	CcSEcCtD
Verapamil—Dyspnoea—Docetaxel—ovarian cancer	0.000121	0.00124	CcSEcCtD
Verapamil—Somnolence—Docetaxel—ovarian cancer	0.000121	0.00123	CcSEcCtD
Verapamil—Tinnitus—Epirubicin—ovarian cancer	0.00012	0.00123	CcSEcCtD
Verapamil—Flushing—Epirubicin—ovarian cancer	0.00012	0.00122	CcSEcCtD
Verapamil—Rhinitis—Doxorubicin—ovarian cancer	0.00012	0.00122	CcSEcCtD
Verapamil—Dyspepsia—Docetaxel—ovarian cancer	0.000119	0.00122	CcSEcCtD
Verapamil—Hepatitis—Doxorubicin—ovarian cancer	0.000119	0.00122	CcSEcCtD
Verapamil—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000119	0.00121	CcSEcCtD
Verapamil—Pharyngitis—Doxorubicin—ovarian cancer	0.000118	0.00121	CcSEcCtD
Verapamil—Hypersensitivity—Paclitaxel—ovarian cancer	0.000118	0.00121	CcSEcCtD
Verapamil—Oedema peripheral—Doxorubicin—ovarian cancer	0.000117	0.0012	CcSEcCtD
Verapamil—Fatigue—Docetaxel—ovarian cancer	0.000117	0.0012	CcSEcCtD
Verapamil—Pain—Docetaxel—ovarian cancer	0.000116	0.00119	CcSEcCtD
Verapamil—Constipation—Docetaxel—ovarian cancer	0.000116	0.00119	CcSEcCtD
Verapamil—Visual impairment—Doxorubicin—ovarian cancer	0.000115	0.00118	CcSEcCtD
Verapamil—Asthenia—Paclitaxel—ovarian cancer	0.000115	0.00118	CcSEcCtD
Verapamil—Alopecia—Epirubicin—ovarian cancer	0.000114	0.00116	CcSEcCtD
Verapamil—Pruritus—Paclitaxel—ovarian cancer	0.000113	0.00116	CcSEcCtD
Verapamil—Erythema multiforme—Doxorubicin—ovarian cancer	0.000113	0.00115	CcSEcCtD
Verapamil—Feeling abnormal—Docetaxel—ovarian cancer	0.000112	0.00114	CcSEcCtD
Verapamil—ABCB1—testis—ovarian cancer	0.000112	0.00155	CbGeAlD
Verapamil—Tinnitus—Doxorubicin—ovarian cancer	0.000111	0.00114	CcSEcCtD
Verapamil—Flushing—Doxorubicin—ovarian cancer	0.000111	0.00113	CcSEcCtD
Verapamil—Diarrhoea—Paclitaxel—ovarian cancer	0.00011	0.00112	CcSEcCtD
Verapamil—Muscle spasms—Epirubicin—ovarian cancer	0.000108	0.0011	CcSEcCtD
Verapamil—Dizziness—Paclitaxel—ovarian cancer	0.000106	0.00108	CcSEcCtD
Verapamil—Vision blurred—Epirubicin—ovarian cancer	0.000106	0.00108	CcSEcCtD
Verapamil—Alopecia—Doxorubicin—ovarian cancer	0.000105	0.00108	CcSEcCtD
Verapamil—Agitation—Epirubicin—ovarian cancer	0.000103	0.00105	CcSEcCtD
Verapamil—Vomiting—Paclitaxel—ovarian cancer	0.000102	0.00104	CcSEcCtD
Verapamil—Rash—Paclitaxel—ovarian cancer	0.000101	0.00103	CcSEcCtD
Verapamil—Dermatitis—Paclitaxel—ovarian cancer	0.000101	0.00103	CcSEcCtD
Verapamil—Vertigo—Epirubicin—ovarian cancer	0.000101	0.00103	CcSEcCtD
Verapamil—Syncope—Epirubicin—ovarian cancer	0.000101	0.00103	CcSEcCtD
Verapamil—Headache—Paclitaxel—ovarian cancer	0.0001	0.00103	CcSEcCtD
Verapamil—Hypersensitivity—Docetaxel—ovarian cancer	0.0001	0.00102	CcSEcCtD
Verapamil—Muscle spasms—Doxorubicin—ovarian cancer	9.98e-05	0.00102	CcSEcCtD
Verapamil—Palpitations—Epirubicin—ovarian cancer	9.91e-05	0.00101	CcSEcCtD
Verapamil—Loss of consciousness—Epirubicin—ovarian cancer	9.86e-05	0.00101	CcSEcCtD
Verapamil—Vision blurred—Doxorubicin—ovarian cancer	9.78e-05	0.001	CcSEcCtD
Verapamil—Asthenia—Docetaxel—ovarian cancer	9.74e-05	0.000996	CcSEcCtD
Verapamil—Convulsion—Epirubicin—ovarian cancer	9.72e-05	0.000994	CcSEcCtD
Verapamil—Hypertension—Epirubicin—ovarian cancer	9.69e-05	0.000991	CcSEcCtD
Verapamil—Pruritus—Docetaxel—ovarian cancer	9.6e-05	0.000982	CcSEcCtD
Verapamil—Arthralgia—Epirubicin—ovarian cancer	9.55e-05	0.000977	CcSEcCtD
Verapamil—Myalgia—Epirubicin—ovarian cancer	9.55e-05	0.000977	CcSEcCtD
Verapamil—Chest pain—Epirubicin—ovarian cancer	9.55e-05	0.000977	CcSEcCtD
Verapamil—Agitation—Doxorubicin—ovarian cancer	9.54e-05	0.000976	CcSEcCtD
Verapamil—Nausea—Paclitaxel—ovarian cancer	9.51e-05	0.000973	CcSEcCtD
Verapamil—Discomfort—Epirubicin—ovarian cancer	9.44e-05	0.000965	CcSEcCtD
Verapamil—Dry mouth—Epirubicin—ovarian cancer	9.34e-05	0.000956	CcSEcCtD
Verapamil—Vertigo—Doxorubicin—ovarian cancer	9.33e-05	0.000954	CcSEcCtD
Verapamil—Syncope—Doxorubicin—ovarian cancer	9.31e-05	0.000952	CcSEcCtD
Verapamil—Diarrhoea—Docetaxel—ovarian cancer	9.29e-05	0.00095	CcSEcCtD
Verapamil—Confusional state—Epirubicin—ovarian cancer	9.23e-05	0.000944	CcSEcCtD
Verapamil—Palpitations—Doxorubicin—ovarian cancer	9.17e-05	0.000938	CcSEcCtD
Verapamil—Oedema—Epirubicin—ovarian cancer	9.16e-05	0.000937	CcSEcCtD
Verapamil—Anaphylactic shock—Epirubicin—ovarian cancer	9.16e-05	0.000937	CcSEcCtD
Verapamil—Loss of consciousness—Doxorubicin—ovarian cancer	9.12e-05	0.000933	CcSEcCtD
Verapamil—Infection—Epirubicin—ovarian cancer	9.1e-05	0.000931	CcSEcCtD
Verapamil—Shock—Epirubicin—ovarian cancer	9.01e-05	0.000922	CcSEcCtD
Verapamil—Convulsion—Doxorubicin—ovarian cancer	8.99e-05	0.00092	CcSEcCtD
Verapamil—Dizziness—Docetaxel—ovarian cancer	8.98e-05	0.000918	CcSEcCtD
Verapamil—Hypertension—Doxorubicin—ovarian cancer	8.96e-05	0.000917	CcSEcCtD
Verapamil—Tachycardia—Epirubicin—ovarian cancer	8.94e-05	0.000914	CcSEcCtD
Verapamil—Hyperhidrosis—Epirubicin—ovarian cancer	8.85e-05	0.000905	CcSEcCtD
Verapamil—Arthralgia—Doxorubicin—ovarian cancer	8.84e-05	0.000904	CcSEcCtD
Verapamil—Chest pain—Doxorubicin—ovarian cancer	8.84e-05	0.000904	CcSEcCtD
Verapamil—Myalgia—Doxorubicin—ovarian cancer	8.84e-05	0.000904	CcSEcCtD
Verapamil—Discomfort—Doxorubicin—ovarian cancer	8.73e-05	0.000893	CcSEcCtD
Verapamil—Dry mouth—Doxorubicin—ovarian cancer	8.64e-05	0.000884	CcSEcCtD
Verapamil—Vomiting—Docetaxel—ovarian cancer	8.63e-05	0.000883	CcSEcCtD
Verapamil—Rash—Docetaxel—ovarian cancer	8.56e-05	0.000876	CcSEcCtD
Verapamil—Hypotension—Epirubicin—ovarian cancer	8.56e-05	0.000875	CcSEcCtD
Verapamil—Dermatitis—Docetaxel—ovarian cancer	8.55e-05	0.000875	CcSEcCtD
Verapamil—Confusional state—Doxorubicin—ovarian cancer	8.54e-05	0.000874	CcSEcCtD
Verapamil—Headache—Docetaxel—ovarian cancer	8.5e-05	0.00087	CcSEcCtD
Verapamil—Anaphylactic shock—Doxorubicin—ovarian cancer	8.47e-05	0.000867	CcSEcCtD
Verapamil—Oedema—Doxorubicin—ovarian cancer	8.47e-05	0.000867	CcSEcCtD
Verapamil—Infection—Doxorubicin—ovarian cancer	8.42e-05	0.000861	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Epirubicin—ovarian cancer	8.34e-05	0.000853	CcSEcCtD
Verapamil—Shock—Doxorubicin—ovarian cancer	8.34e-05	0.000853	CcSEcCtD
Verapamil—Insomnia—Epirubicin—ovarian cancer	8.28e-05	0.000847	CcSEcCtD
Verapamil—Tachycardia—Doxorubicin—ovarian cancer	8.27e-05	0.000846	CcSEcCtD
Verapamil—Paraesthesia—Epirubicin—ovarian cancer	8.22e-05	0.000841	CcSEcCtD
Verapamil—Hyperhidrosis—Doxorubicin—ovarian cancer	8.19e-05	0.000838	CcSEcCtD
Verapamil—Dyspnoea—Epirubicin—ovarian cancer	8.16e-05	0.000835	CcSEcCtD
Verapamil—Somnolence—Epirubicin—ovarian cancer	8.14e-05	0.000833	CcSEcCtD
Verapamil—ABCB1—lymph node—ovarian cancer	8.1e-05	0.00112	CbGeAlD
Verapamil—Nausea—Docetaxel—ovarian cancer	8.06e-05	0.000825	CcSEcCtD
Verapamil—Dyspepsia—Epirubicin—ovarian cancer	8.06e-05	0.000824	CcSEcCtD
Verapamil—Hypotension—Doxorubicin—ovarian cancer	7.92e-05	0.00081	CcSEcCtD
Verapamil—Fatigue—Epirubicin—ovarian cancer	7.89e-05	0.000808	CcSEcCtD
Verapamil—Pain—Epirubicin—ovarian cancer	7.83e-05	0.000801	CcSEcCtD
Verapamil—Constipation—Epirubicin—ovarian cancer	7.83e-05	0.000801	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	7.72e-05	0.00079	CcSEcCtD
Verapamil—Insomnia—Doxorubicin—ovarian cancer	7.66e-05	0.000784	CcSEcCtD
Verapamil—Paraesthesia—Doxorubicin—ovarian cancer	7.61e-05	0.000778	CcSEcCtD
Verapamil—Dyspnoea—Doxorubicin—ovarian cancer	7.55e-05	0.000773	CcSEcCtD
Verapamil—Feeling abnormal—Epirubicin—ovarian cancer	7.55e-05	0.000772	CcSEcCtD
Verapamil—Somnolence—Doxorubicin—ovarian cancer	7.53e-05	0.00077	CcSEcCtD
Verapamil—Dyspepsia—Doxorubicin—ovarian cancer	7.46e-05	0.000763	CcSEcCtD
Verapamil—Fatigue—Doxorubicin—ovarian cancer	7.3e-05	0.000747	CcSEcCtD
Verapamil—Urticaria—Epirubicin—ovarian cancer	7.27e-05	0.000744	CcSEcCtD
Verapamil—Constipation—Doxorubicin—ovarian cancer	7.24e-05	0.000741	CcSEcCtD
Verapamil—Pain—Doxorubicin—ovarian cancer	7.24e-05	0.000741	CcSEcCtD
Verapamil—Feeling abnormal—Doxorubicin—ovarian cancer	6.98e-05	0.000714	CcSEcCtD
Verapamil—Hypersensitivity—Epirubicin—ovarian cancer	6.75e-05	0.00069	CcSEcCtD
Verapamil—Urticaria—Doxorubicin—ovarian cancer	6.73e-05	0.000688	CcSEcCtD
Verapamil—Asthenia—Epirubicin—ovarian cancer	6.57e-05	0.000672	CcSEcCtD
Verapamil—Pruritus—Epirubicin—ovarian cancer	6.48e-05	0.000663	CcSEcCtD
Verapamil—Diarrhoea—Epirubicin—ovarian cancer	6.26e-05	0.000641	CcSEcCtD
Verapamil—Hypersensitivity—Doxorubicin—ovarian cancer	6.24e-05	0.000639	CcSEcCtD
Verapamil—Asthenia—Doxorubicin—ovarian cancer	6.08e-05	0.000622	CcSEcCtD
Verapamil—Dizziness—Epirubicin—ovarian cancer	6.05e-05	0.000619	CcSEcCtD
Verapamil—Pruritus—Doxorubicin—ovarian cancer	5.99e-05	0.000613	CcSEcCtD
Verapamil—Vomiting—Epirubicin—ovarian cancer	5.82e-05	0.000596	CcSEcCtD
Verapamil—Diarrhoea—Doxorubicin—ovarian cancer	5.8e-05	0.000593	CcSEcCtD
Verapamil—Rash—Epirubicin—ovarian cancer	5.77e-05	0.000591	CcSEcCtD
Verapamil—Dermatitis—Epirubicin—ovarian cancer	5.77e-05	0.00059	CcSEcCtD
Verapamil—Headache—Epirubicin—ovarian cancer	5.74e-05	0.000587	CcSEcCtD
Verapamil—Dizziness—Doxorubicin—ovarian cancer	5.6e-05	0.000573	CcSEcCtD
Verapamil—Nausea—Epirubicin—ovarian cancer	5.44e-05	0.000556	CcSEcCtD
Verapamil—Vomiting—Doxorubicin—ovarian cancer	5.39e-05	0.000551	CcSEcCtD
Verapamil—Rash—Doxorubicin—ovarian cancer	5.34e-05	0.000546	CcSEcCtD
Verapamil—Dermatitis—Doxorubicin—ovarian cancer	5.34e-05	0.000546	CcSEcCtD
Verapamil—Headache—Doxorubicin—ovarian cancer	5.31e-05	0.000543	CcSEcCtD
Verapamil—Nausea—Doxorubicin—ovarian cancer	5.03e-05	0.000515	CcSEcCtD
Verapamil—ABCB11—Metabolism—PIK3CD—ovarian cancer	7.06e-06	8.46e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—FASN—ovarian cancer	7.04e-06	8.43e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.04e-06	8.43e-05	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	6.98e-06	8.36e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PIK3CD—ovarian cancer	6.96e-06	8.34e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—SLC5A5—ovarian cancer	6.92e-06	8.29e-05	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—AKT1—ovarian cancer	6.87e-06	8.22e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYTB—ovarian cancer	6.85e-06	8.2e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PTEN—ovarian cancer	6.84e-06	8.19e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—SLC2A1—ovarian cancer	6.84e-06	8.19e-05	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—AKT1—ovarian cancer	6.82e-06	8.16e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ABCB1—ovarian cancer	6.8e-06	8.14e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PIK3CD—ovarian cancer	6.77e-06	8.11e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	6.71e-06	8.03e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—SLC2A1—ovarian cancer	6.69e-06	8.01e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—YAP1—ovarian cancer	6.68e-06	7.99e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—TYMS—ovarian cancer	6.68e-06	7.99e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CAV1—ovarian cancer	6.63e-06	7.94e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.61e-06	7.92e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.61e-06	7.91e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PIK3CB—ovarian cancer	6.59e-06	7.89e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP1B1—ovarian cancer	6.56e-06	7.85e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PTEN—ovarian cancer	6.53e-06	7.82e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—YAP1—ovarian cancer	6.52e-06	7.8e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.51e-06	7.79e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PTEN—ovarian cancer	6.48e-06	7.76e-05	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—AKT1—ovarian cancer	6.45e-06	7.73e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP1B1—ovarian cancer	6.41e-06	7.68e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PIK3CD—ovarian cancer	6.34e-06	7.59e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.33e-06	7.58e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CAV1—ovarian cancer	6.3e-06	7.54e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PIK3CB—ovarian cancer	6.16e-06	7.37e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—YAP1—ovarian cancer	6.14e-06	7.35e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—FASN—ovarian cancer	6.1e-06	7.3e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—YAP1—ovarian cancer	6.09e-06	7.29e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PIK3CB—ovarian cancer	6.07e-06	7.27e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PIK3CG—ovarian cancer	6.04e-06	7.23e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.02e-06	7.21e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.02e-06	7.2e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—SLC5A5—ovarian cancer	6e-06	7.18e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—BRIP1—ovarian cancer	5.99e-06	7.17e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPP1CC—ovarian cancer	5.99e-06	7.17e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PIK3CB—ovarian cancer	5.9e-06	7.07e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	5.9e-06	7.06e-05	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	5.89e-06	7.06e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CAV1—ovarian cancer	5.83e-06	6.98e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	5.82e-06	6.97e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.81e-06	6.95e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—SLC2A1—ovarian cancer	5.79e-06	6.94e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CAV1—ovarian cancer	5.78e-06	6.92e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	5.74e-06	6.87e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PTEN—ovarian cancer	5.69e-06	6.82e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	5.69e-06	6.81e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.67e-06	6.79e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.65e-06	6.77e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—ERBB2—ovarian cancer	5.6e-06	6.7e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP1B1—ovarian cancer	5.55e-06	6.65e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PIK3CB—ovarian cancer	5.52e-06	6.61e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MTOR—ovarian cancer	5.52e-06	6.61e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—FASN—ovarian cancer	5.44e-06	6.52e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ABCB1—ovarian cancer	5.4e-06	6.47e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CAV1—ovarian cancer	5.38e-06	6.44e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—SLC5A5—ovarian cancer	5.35e-06	6.41e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PTEN—ovarian cancer	5.32e-06	6.37e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CG—ovarian cancer	5.31e-06	6.36e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—FASN—ovarian cancer	5.31e-06	6.36e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PIK3CD—ovarian cancer	5.31e-06	6.35e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—TYMS—ovarian cancer	5.31e-06	6.35e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.3e-06	6.34e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ABCB1—ovarian cancer	5.28e-06	6.32e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CG—ovarian cancer	5.27e-06	6.3e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PTEN—ovarian cancer	5.24e-06	6.28e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—SLC5A5—ovarian cancer	5.23e-06	6.26e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—YAP1—ovarian cancer	5.2e-06	6.23e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—TYMS—ovarian cancer	5.19e-06	6.21e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CDKN1B—ovarian cancer	5.18e-06	6.21e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—SLC2A1—ovarian cancer	5.17e-06	6.19e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.15e-06	6.16e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	5.14e-06	6.16e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PTEN—ovarian cancer	5.1e-06	6.11e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.06e-06	6.06e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—SLC2A1—ovarian cancer	5.05e-06	6.04e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	5.04e-06	6.04e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—FASN—ovarian cancer	5.01e-06	5.99e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—FASN—ovarian cancer	4.96e-06	5.94e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP1B1—ovarian cancer	4.96e-06	5.94e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	4.93e-06	5.9e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—SLC5A5—ovarian cancer	4.92e-06	5.9e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.9e-06	5.87e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CG—ovarian cancer	4.9e-06	5.87e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CTNNB1—ovarian cancer	4.9e-06	5.86e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—SLC5A5—ovarian cancer	4.88e-06	5.84e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP1B1—ovarian cancer	4.84e-06	5.79e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PIK3CA—ovarian cancer	4.83e-06	5.78e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PTEN—ovarian cancer	4.77e-06	5.71e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—SLC2A1—ovarian cancer	4.76e-06	5.69e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—SLC2A1—ovarian cancer	4.71e-06	5.64e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CD—ovarian cancer	4.67e-06	5.59e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CD—ovarian cancer	4.63e-06	5.54e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PIK3CB—ovarian cancer	4.63e-06	5.54e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.62e-06	5.53e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PIK3CA—ovarian cancer	4.6e-06	5.51e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ABCB1—ovarian cancer	4.57e-06	5.48e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PIK3CA—ovarian cancer	4.57e-06	5.47e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP1B1—ovarian cancer	4.56e-06	5.46e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.53e-06	5.42e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP1B1—ovarian cancer	4.52e-06	5.41e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—TYMS—ovarian cancer	4.49e-06	5.38e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PTEN—ovarian cancer	4.44e-06	5.32e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	4.4e-06	5.26e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	4.4e-06	5.26e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.37e-06	5.24e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CD—ovarian cancer	4.31e-06	5.16e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PPP2R1A—ovarian cancer	4.29e-06	5.14e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CAV1—ovarian cancer	4.27e-06	5.12e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—STAT3—ovarian cancer	4.27e-06	5.11e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—NRAS—ovarian cancer	4.26e-06	5.1e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—FASN—ovarian cancer	4.24e-06	5.08e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CAV1—ovarian cancer	4.18e-06	5e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—SLC5A5—ovarian cancer	4.17e-06	4.99e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ABCB1—ovarian cancer	4.08e-06	4.89e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MAPK3—ovarian cancer	4.08e-06	4.88e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CB—ovarian cancer	4.07e-06	4.87e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	4.04e-06	4.84e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CB—ovarian cancer	4.03e-06	4.83e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—SLC2A1—ovarian cancer	4.03e-06	4.82e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PIK3CA—ovarian cancer	4.02e-06	4.81e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—YAP1—ovarian cancer	4.01e-06	4.81e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—TYMS—ovarian cancer	4.01e-06	4.8e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	4.01e-06	4.8e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PTEN—ovarian cancer	4e-06	4.79e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.99e-06	4.78e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MYC—ovarian cancer	3.97e-06	4.75e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.94e-06	4.72e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—AKT1—ovarian cancer	3.94e-06	4.72e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—TYMS—ovarian cancer	3.91e-06	4.69e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CG—ovarian cancer	3.89e-06	4.66e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MAPK1—ovarian cancer	3.88e-06	4.65e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—EGFR—ovarian cancer	3.88e-06	4.65e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP1B1—ovarian cancer	3.86e-06	4.62e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CG—ovarian cancer	3.81e-06	4.56e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTEN—ovarian cancer	3.8e-06	4.55e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—AKT1—ovarian cancer	3.76e-06	4.5e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CB—ovarian cancer	3.75e-06	4.5e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ABCB1—ovarian cancer	3.75e-06	4.5e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PIK3CA—ovarian cancer	3.75e-06	4.49e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—AKT1—ovarian cancer	3.73e-06	4.47e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ABCB1—ovarian cancer	3.72e-06	4.46e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PIK3CA—ovarian cancer	3.7e-06	4.43e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—TYMS—ovarian cancer	3.69e-06	4.41e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—KRAS—ovarian cancer	3.67e-06	4.39e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—TYMS—ovarian cancer	3.66e-06	4.38e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CAV1—ovarian cancer	3.62e-06	4.33e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PIK3CA—ovarian cancer	3.6e-06	4.31e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTEN—ovarian cancer	3.52e-06	4.21e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTEN—ovarian cancer	3.49e-06	4.17e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.46e-06	4.14e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	3.43e-06	4.1e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CD—ovarian cancer	3.42e-06	4.1e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.41e-06	4.08e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PIK3CA—ovarian cancer	3.37e-06	4.03e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CD—ovarian cancer	3.35e-06	4.01e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CG—ovarian cancer	3.3e-06	3.95e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—AKT1—ovarian cancer	3.28e-06	3.93e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—FASN—ovarian cancer	3.27e-06	3.92e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTEN—ovarian cancer	3.24e-06	3.88e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CAV1—ovarian cancer	3.23e-06	3.87e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.22e-06	3.85e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ABCB1—ovarian cancer	3.18e-06	3.81e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CAV1—ovarian cancer	3.15e-06	3.78e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	3.13e-06	3.75e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—TYMS—ovarian cancer	3.12e-06	3.74e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—HRAS—ovarian cancer	3.12e-06	3.73e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.11e-06	3.72e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.09e-06	3.7e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—AKT1—ovarian cancer	3.07e-06	3.67e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—AKT1—ovarian cancer	3.02e-06	3.62e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CB—ovarian cancer	2.98e-06	3.57e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—IL6—ovarian cancer	2.98e-06	3.57e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.98e-06	3.57e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CAV1—ovarian cancer	2.97e-06	3.56e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CAV1—ovarian cancer	2.95e-06	3.53e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CG—ovarian cancer	2.94e-06	3.52e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—AKT1—ovarian cancer	2.94e-06	3.52e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CB—ovarian cancer	2.92e-06	3.49e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CD—ovarian cancer	2.9e-06	3.47e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CG—ovarian cancer	2.87e-06	3.44e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PIK3CA—ovarian cancer	2.82e-06	3.38e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.81e-06	3.37e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—AKT1—ovarian cancer	2.75e-06	3.29e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CG—ovarian cancer	2.71e-06	3.24e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.68e-06	3.21e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	2.68e-06	3.21e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.64e-06	3.17e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CD—ovarian cancer	2.59e-06	3.1e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTEN—ovarian cancer	2.58e-06	3.09e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—AKT1—ovarian cancer	2.56e-06	3.07e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CB—ovarian cancer	2.53e-06	3.02e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CD—ovarian cancer	2.52e-06	3.02e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTEN—ovarian cancer	2.52e-06	3.02e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CAV1—ovarian cancer	2.52e-06	3.01e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CA—ovarian cancer	2.48e-06	2.97e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CA—ovarian cancer	2.46e-06	2.94e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.45e-06	2.94e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—TYMS—ovarian cancer	2.41e-06	2.89e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.4e-06	2.88e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.38e-06	2.85e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.36e-06	2.82e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—AKT1—ovarian cancer	2.3e-06	2.76e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.29e-06	2.75e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CA—ovarian cancer	2.29e-06	2.74e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.25e-06	2.7e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.2e-06	2.63e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—AKT1—ovarian cancer	2.19e-06	2.62e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTEN—ovarian cancer	2.18e-06	2.61e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.07e-06	2.48e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.06e-06	2.46e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—AKT1—ovarian cancer	2.03e-06	2.43e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.02e-06	2.41e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—AKT1—ovarian cancer	2.01e-06	2.41e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTEN—ovarian cancer	1.95e-06	2.33e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CAV1—ovarian cancer	1.94e-06	2.33e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTEN—ovarian cancer	1.9e-06	2.28e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—AKT1—ovarian cancer	1.87e-06	2.24e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CA—ovarian cancer	1.82e-06	2.18e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTEN—ovarian cancer	1.79e-06	2.15e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CA—ovarian cancer	1.78e-06	2.13e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTEN—ovarian cancer	1.78e-06	2.13e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.77e-06	2.12e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.76e-06	2.1e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.56e-06	1.86e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.54e-06	1.84e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTEN—ovarian cancer	1.52e-06	1.82e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AKT1—ovarian cancer	1.49e-06	1.78e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AKT1—ovarian cancer	1.45e-06	1.74e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.37e-06	1.65e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.36e-06	1.62e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.34e-06	1.61e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.26e-06	1.51e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AKT1—ovarian cancer	1.26e-06	1.51e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.25e-06	1.5e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTEN—ovarian cancer	1.17e-06	1.4e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AKT1—ovarian cancer	1.12e-06	1.34e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AKT1—ovarian cancer	1.1e-06	1.31e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.07e-06	1.28e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AKT1—ovarian cancer	1.03e-06	1.24e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AKT1—ovarian cancer	1.02e-06	1.23e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AKT1—ovarian cancer	8.75e-07	1.05e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CA—ovarian cancer	8.27e-07	9.9e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKT1—ovarian cancer	6.75e-07	8.08e-06	CbGpPWpGaD
